对冠心病心肌缺血患者使用替格瑞洛与氯吡格雷治疗的临床疗效分析  

Analysis of Clinical Efficacy of Ticagrelor and Clopidogrel in Patients with Coronary Heart Disease and Myocardial Ischemia

作　　者：韩玉泽[1] HAN Yu-ze(Department of Cardiology,Dalian Friendship Hospital,Dalian 116001,China)

机构地区：[1]大连市友谊医院心内二科,辽宁大连116001

出　　处：《中国医药指南》2020年第9期21-22,共2页Guide of China Medicine

摘　　要：目的探讨冠心病心肌缺血患者使用替格瑞洛与氯吡格雷治疗的临床疗效。方法选取2018年1月至2019年1月在大连市友谊医院就诊的80例冠心病心肌缺血患者,随机分为试验组和对照组,对照组40例采取氯吡格雷治疗,试验组40例采取替替格瑞洛治疗,比较两组患者的心率、收缩压、舒张压水平,以及临床有效率情况。结果试验组舒张压、收缩压及心率水平显著优于对照组(P<0.05);试验组临床有效率高于对照组,差异有统计学意义(P<0.05)。结论对冠心病心肌缺血患使用替格瑞洛治疗,可以有效的提高临床有效率,稳定患者的血压、心率,值得在临床推广。Objective To investigate the clinical efficacy of glilol and clopidogrel in the treatment of myocardial ischemia in patients with coronary heart disease.Methods From January 2018 to January 2019 in the Dalian friendship hospital hospital,80 cases of 80 patients with coronary heart disease,myocardial ischemia,randomly divided into experimental group and the control group,control group 40 cases treated with clopidogrel,experimental group 40 cases take for Greg treatment,compared two groups of patients with heart rate,systolic pressure,diastolic blood pressure level,as well as clinical effectiveness.Results Diastolic blood pressure,systolic blood pressure and heart rate of the experimental group were significantly better than those of the control group(P<0.05).The clinical effective rate of the experimental group was higher than that of the control group,and the difference was statistically significant(P<0.05).Conclusion The use of glilol and clopidogrel in the treatment of myocardial ischemia patients with coronary heart disease can effectively improve the clinical efficiency and stabilize the patient's blood pressure and heart rate,which is worthy of clinical promotion.

关 键 词：氯吡格雷 替格瑞洛 冠心病 心肌缺血 

分 类 号：R541.4[医药卫生—心血管疾病]